Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
In addition to their role in controlling water and salt homeostasis, recent work suggests that aldosterone and mineralocorticoid receptors (MR) may be involved in adipocyte biology. This is of particular relevance given the role of MR as a high‐affinity receptor for both mineralocorticoids and glucocorticoids. We have thus examined the effect of aldosterone and MR on white adipose cell differentiation. When cells are cultured in a steroid‐free medium, aldosterone promotes acquisition of the adipose phenotype of 3T3‐L1 and 3T3‐F442A cells in a time‐, dose‐, and MR‐dependent manner. In contrast, late and long‐term exposure to dexamethasone inhibits adipocyte terminal maturation. The aldosterone effect on adipose maturation was accompanied by induction of PPARγ mRNA expression, which was blocked by the MR antagonist spironolactone. Under permissive culture conditions, specific MR down‐regulation by siRNAs markedly inhibited 3T3‐L1 differentiation by interfering with the transcriptional control of adipogenesis, an effect not mimicked by specific inactivation of the glucocorticoid receptor. These results demonstrate that MR represents an important proadipogenic transcription factor that may mediate both aldosterone and glucocorticoid effects on adipose tissue development. MR thus may be of pathophysiological relevance to the development of obesity and the metabolic syndrome.–Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., Zennaro, M‐C. Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis. FASEB J. 21, 2185–2194 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aldosterone increases pre-adipocyte differentiation tissue in vivo (39)”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [39]
In the citing paper
“The adipocyte MRs may mediate a proadipogenic effect of both aldosterone () and GCs ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [175]
In the citing paper
“MRs on adipocytes promoted the expression of inflammatory adipokines (-), giving rise to lower insulin receptor expression and impaired insulin-induced glucose uptake ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [175]
Citations
Cites
1 retracted
Kitagawa, H., Yanagisawa, J., Fuse, H., Ogawa, S., Yogiashi, Y., Okuno, A., Nagasawa, H., Nakajima, T., Matsumoto, T., & Kato, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3698-3706.2002 · Cited by 101 · cited 1×
“This would not be surprising, since aldosterone and glucocorticoids have been shown to recruit different coregulators to MR-responsive promoters, thus differentially affecting gene transcription (24).”
BackgroundRetractedStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Understanding Adipocyte Differentiation
GREGOIRE, F. M., SMAS, C. M., & SUL, H. S. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.3.783 · Cited by 2,376 · cited 2×
“To better elucidate the mechanism of aldosterone action, we asked whether its proadipogenic effects were reproduced in 3T3-F442A cells, which are generally regarded as a model with a more advanced commitment in the adipose differentiation process (1); consistent with this, 3T3-F442A cell differentiation is independent…”
BackgroundArriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946 · cited 2×
“Exposure to aldosterone for 7 days was accompanied by a dose-dependent increase in cell triglyceride accumulation and G3PDH activity (Fig. 3C), with an EC50 value between 0.3 and 0.6 nM, consistent with the affinity of the MR for aldosterone ( 7 ).”
BackgroundInfluentialTranscriptional regulation of adipogenesis
Rosen, E. D., Walkey, C. J., Puigserver, P., & Spiegelman, B. M. (2000) · Genes & Development · doi:10.1101/gad.14.11.1293 · Cited by 1,898 · cited 1×
“It is generally recognized that C/EBP is involved early and transiently in the control of adipogenesis, while PPAR and C/EBP are involved more distally (26), and that expression of the relevant genes is regulated in a sequential and coordinated manner by environmental proadipogenic factors.”
BackgroundLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 3×
“In vivo, convincing evidence exists for a major role of glucocorticoids on adipose differentiation, as elegantly demonstrated in transgenic animal models (2).”
BackgroundC/EBPα induces adipogenesis through PPARγ: a unified pathway
Rosen, E. D., Hsu, C.-H., Wang, X., Sakai, S., Freeman, M. W., Gonzalez, F. J., & Spiegelman, B. M. (2002) · Genes & Development · doi:10.1101/gad.948702 · Cited by 1,494 · cited 1×
“sufficient to promote adipogenesis (27).”
Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015 · cited 1×
“Also supporting this hypothesis is recent evidence coming from anatomical profiling of nuclear receptor expression, showing that MR belongs to a cluster of receptors highly expressed in all tissues and is crucial for maintaining global basal metabolic functions ( 32 ).”
Background
Research works printed but not linked: 1
- 10.1210/mend.13.12.0384 · doi:10.1210/mend.13.12.0384 · Paper page
Cited by
Lee, M.-J., Pramyothin, P., Karastergiou, K., & Fried, S. K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.029 · Cited by 380
“Recent studies demonstrate that MR rather than GR is important for the proadipogenic effects of GCs in 3T3-L1 and mouse and human preadipocytes [13,14,45].”
BackgroundRuiz-Ojeda, F., Rupérez, A., Gomez-Llorente, C., Gil, A., & Aguilera, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071040 · Cited by 375
“However, the adipogenesis of MEFs cells can be induced for eight days with a standard differentiation induction medium containing 0.5 mM IBMX, 1 µM DEX, 10 µg/mL insulin, 10 µM troglitazone, and 10% (v/v) FBS [27].”
BackgroundInfluentialBriones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190223 · Cited by 375
“Previous studies showed that aldosterone promotes 3T3-L1 preadipocyte differentiation through MR but not through GR.(16) Ang II is an endogenous stimulus for adrenal aldosterone secretion.”
BackgroundTranscriptional Regulation of Adipogenesis
de Sá, P. M., Richard, A. J., Hang, H., & Stephens, J. M. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c160022 · Cited by 360
“This is important since MR has a high-affinity for both mineralocorticoids and GCs. Studies have shown that aldosterone promotes adipogenesis in both 3T3-L1 and 3T3-F442A cells in an MR-dependent manner (35).”
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351
“Similar to the nongenomic actions of the mineralocorticoid receptor in other nonepithelial tissues, the adipocyte mineralocorticoid receptors may mediate a proadipogenic effect of both aldosterone (39) and glucocorticoids (41).”
Guo, C., Ricchiuti, V., Lian, B. Q., Yao, T. M., Coutinho, P., Romero, J. R., Li, J., Williams, G. H., & Adler, G. K. (2008) · Circulation · doi:10.1161/circulationaha.107.748640 · Cited by 342
Jaisser, F., & Farman, N. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011106 · Cited by 327
“Ex vivo experiments indicate that activation of MR by aldosterone (Caprio et al., 2007) or glucocorticoids (Hirata et al.”
BackgroundThe Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological Biology
Viengchareun, S., Le Menuet, D., Martinerie, L., Munier, M., Tallec, L. P.-L., & Lombès, M. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05012 · Cited by 316
“Recent studies have shown MR to be expressed at the transcript and protein level in adipose tissues, both in white [Caprio et al., 2007; Fu et al., 2005; Rondinone et al., 1993] and brown adipocytes [Penfornis et al.”
Self-citationType 2 Diabetes Mellitus and Hypertension
Lastra, G., Syed, S., Kurukulasuriya, L. R., Manrique, C., & Sowers, J. R. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.005 · Cited by 307
“Adipose tissue is known to produce a lipid-soluble factor that stimulates aldosterone production from the adrenal zona glomerulosa (26, 27).”
Targeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
“Moreover, the expression of mineralocorticoid receptors in preadipocytes is important for their differentiation into adipocytes.(233) Higher levels of Aldo could contribute to inflammation through enhancing the expression of adhesion molecules such as ICAM.”
BackgroundMolecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
“Aldosterone induces adipogenesis, w ile MR antagonis s reduce preadipocyte differentia on in itr [97,98].”
BackgroundSelf-citationConvertible visceral fat as a therapeutic target to curb obesity
Giordano, A., Frontini, A., & Cinti, S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.31 · Cited by 232
A new look at the renin–angiotensin system—Focusing on the vascular system
Nguyen Dinh Cat, A., & Touyz, R. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.09.010 · Cited by 200
Rossi, G. P., Belfiore, A., Bernini, G., Fabris, B., Caridi, G., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0251 · Cited by 188
“The alternative hypothesis that aldosterone plays a role in determining fat deposition, and therefore BMI, cannot be dismissed in that it was recently shown that aldosterone acts on the mineralocorticoid receptor to induce peroxisome proliferator activated receptor mRNA expression, thus promoting white adipose cell di…”
BackgroundAhmed, S., & Atlas, E. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.95 · Cited by 187
Metabolic comorbidities in Cushing's syndrome
Ferraù, F., & Korbonits, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0354 · Cited by 187
Armani, A., Cinti, F., Marzolla, V., Morgan, J., Cranston, G. A., Antelmi, A., Carpinelli, G., Canese, R., Pagotto, U., Quarta, C., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-245415 · Cited by 166
“Notably, treatment of 3T3-L1 preadipocytes with aldosterone, at concentrations known to specifically bind the MR (1), demonstrated a significant increase in the autophagic rate, whereas spiro and DRSP completely prevented this response, showing for the first time a role for adipocyte MR in controlling the autophagic r…”
BackgroundMethodInfluentialSelf-citationCellular models for understanding adipogenesis, adipose dysfunction, and obesity
Armani, A., Mammi, C., Marzolla, V., Calanchini, M., Antelmi, A., Rosano, G. M. C., Fabbri, A., & Caprio, M. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22598 · Cited by 166
“Interestingly, dxm is a powerful inductor of adipogenesis at early stages of differentiation, but displays antiadipogenic effects when added at later stages of adipose maturation, indicating that the effects of hormones are strictly timedependent [Caprio et al., 2007].”
BackgroundInfluentialSelf-citationThe Role of Aldosterone in Obesity-Related Hypertension
Kawarazaki, W., & Fujita, T. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw003 · Cited by 165
Stowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 159
“In addition to epithelial cells, the MR has been identified in a wide variety of nonepithelial tissues including endothelial cells, vascular smooth muscle, macrophages, adipocytes, cardiomyocytes, and the hippocampus of the brain (69, 112, 164, 296, 321, 325, 393, 516, 583).”
BackgroundSchäfer, N., Lohmann, C., Winnik, S., van Tits, L. J., Miranda, M. X., Vergopoulos, A., Ruschitzka, F., Nussberger, J., Berger, S., Lüscher, T. F., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht095 · Cited by 158
Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension
Whaley-Connell, A., Johnson, M. S., & Sowers, J. R. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.12.004 · Cited by 153
Salt, aldosterone, and insulin resistance: impact on the cardiovascular system
Lastra, G., Dhuper, S., Johnson, M. S., & Sowers, J. R. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.123 · Cited by 169
The glucocorticoid receptor: cause of or cure for obesity?
John, K., Marino, J. S., Sánchez, E. R., & Hinds, T. D. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00478.2015 · Cited by 162
Caprio, M., Antelmi, A., Chetrite, G., Muscat, A., Mammi, C., Marzolla, V., Fabbri, A., Zennaro, M.-C., & Fève, B. (2011) · Endocrinology · doi:10.1210/en.2010-0674 · Cited by 144
Self-citationGlucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism
Marzolla, V., Armani, A., Zennaro, M., Cinti, F., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.011 · Cited by 143
“Consistent with this hypothesis, transient knock-down of MR can significantly inhibit dexamethasone-induced 3T3-L1 adipose conversion, whereas GR down-regulation does not, indicating that MR is the principal contributor to corticosteroid-induced adipogenesis (Caprio et al., 2007).”
BackgroundSelf-citationExercise in the Metabolic Syndrome
Golbidi, S., Mesdaghinia, A., & Laher, I. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/349710 · Cited by 122
“Adipose tissue produces a lipid soluble factor that stimulates aldosterone secretion [75], which is then (along with other glucocorticoids) able to enhance adipogenesis and increase macrophage infiltration into fat depots [75, 76].”
BackgroundTop‐down and bottom‐up control of stress‐coping
de Kloet, E. R., de Kloet, S. F., de Kloet, C. S., & de Kloet, A. D. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12675 · Cited by 135
Hoppmann, J., Perwitz, N., Meier, B., Fasshauer, M., Hadaschik, D., Lehnert, H., & Klein, J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0292 · Cited by 122
“A previous study suggests an involvement of the MR in corticosteroid-induced adipogenesis (Caprio et al. 2007).”
BackgroundResultInfluentialAdipose Tissue: Physiology to Metabolic Dysfunction
Richard, A. J., White, U. A., Elks, C. M., & Stephens, J. M. (2020) · Europe PMC (PubMed Central) · Cited by 224
DeRijk, R. H., van Leeuwen, N., Klok, M. D., & Zitman, F. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.012 · Cited by 117
“Recently, a role for the mineralocorticoid receptor in the development of adipose tissue and metabolic control has been proposed (Caprio et al., 2007).”
BackgroundEffects of aldosterone on insulin sensitivity and secretion
Luther, J. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.016 · Cited by 114
“Aldosterone induces pre-adipocyte differentiation in vitro via the MR (83).”
Modulation of glucose metabolism by the renin-angiotensin-aldosterone system
Favre, G. A., Esnault, V. L. M., & Van Obberghen, E. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2014 · Cited by 114
“In addition, MR upregulate PPAR expression in differentiating 3T3-L1 adipocytes (19).”
BackgroundUrbanet, R., Nguyen Dinh Cat, A., Feraco, A., Venteclef, N., El Mogrhabi, S., Sierra-Ramos, C., Alvarez de la Rosa, D., Adler, G. K., Quilliot, D., Rossignol, P., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04981 · Cited by 114
“a pivotal role of MR activation per se either by mineralocorticoids or glucocorticoids.(9) Hirata et al(10) demonstrated in”
BackgroundResultInfluentialWada, T., Ohshima, S., Fujisawa, E., Koya, D., Tsuneki, H., & Sasaoka, T. (2009) · Endocrinology · doi:10.1210/en.2008-1018 · Cited by 114
“Aldosterone induced degradation of IRS1 and IRS2 through GR but not mineralocorticoid receptor (MR) Adipose tissue is known to express both MR and GR (26).”
BackgroundOlivier, A., Pitt, B., Girerd, N., Lamiral, Z., Machu, J.-L., McMurray, J. J. V., Swedberg, K., van Veldhuisen, D. J., Collier, T. J., Pocock, S. J., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.792 · Cited by 112
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
Luther, J. M., Luo, P., Kreger, M. T., Brissova, M., Dai, C., Whitfield, T. T., Kim, H. S., Wasserman, D. H., Powers, A. C., & Brown, N. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2158-9 · Cited by 109
“Although previous studies have demonstrated that aldosterone and the MR promote adipocyte differentiation in vitro [44], As mice exhibited no difference in adiposity measures, suggesting that aldosterone deficiency alone may not reduce adipose mass.”
ResultThe mineralocorticoid receptor and its coregulators
Yang, J., & Young, M. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0031 · Cited by 107
“It also plays important roles in non-epithelial tissues, such as cardiac myocytes, blood vessels, the hippocampus and adipose tissue (Lombes et al. 1992, 2000, Meijer 2002, Caprio et al. 2007).”
BackgroundMineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease
Bene, N. C., Alcaide, P., Wortis, H. H., & Jaffe, I. Z. (2014) · Steroids · doi:10.1016/j.steroids.2014.04.005 · Cited by 112
Aldosterone: A forgotten mediator of the relationship between psychological stress and heart disease
Kubzansky, L. D., & Adler, G. K. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.005 · Cited by 103
Extrarenal effects of aldosterone
Cat, A. N. D., & Jaisser, F. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32834fb25b · Cited by 115
“Adipocytes express all the elements of the RAAS, including the mineralocorticoid receptor [11].”
BackgroundLee, M.-J., & Fried, S. K. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.6 · Cited by 99
“MR has been shown to be expressed in 3T3-L1 preadipocytes at 30-50 times lower levels than GR and its expression levels increase with differentiation (9).”
BackgroundResultInfluentialMechanisms of ligand specificity of the mineralocorticoid receptor
Fuller, P. J., Yao, Y., Yang, J., & Young, M. J. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0372 · Cited by 116
“In other tissues such as adipose tissue, where the receptor appears to play a fundamental role in adipocyte differentiation (Caprio et al. 2007), there is no suggestion that sodium transport is relevant.”
BackgroundEstrogen Receptor Inhibits Mineralocorticoid Receptor Transcriptional Regulatory Function
Mueller, K. B., Lu, Q. R., Mohammad, N. N., Luu, V., McCurley, A., Williams, G. H., Adler, G. K., Karas, R. H., & Jaffe, I. Z. (2014) · Endocrinology · doi:10.1210/en.2014-1270 · Cited by 108
Pan, S., Yang, X., Jia, Y., Li, R., & Zhao, R. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24486 · Cited by 97
“GR is known to be involved in the regulation of cell differentiation (Caprio et al., 2007), and inhibition of GR expression may, therefore, be indicative of suppressed adipogenesis in adipocytes exposed to miR-130bMV.”
BackgroundAdipocytes, aldosterone and obesity-related hypertension
Dinh Cat, A. N., Friederich-Persson, M., White, A., & Touyz, R. M. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0025 · Cited by 96
“studies have shown that MR, rather than the GR, is required for normal steroid-induced adipogenesis (Caprio et al. 2007).”
BackgroundHinds, T. D., Stechschulte, L. A., Cash, H. A., Whisler, D., Banerjee, A., Yong, W., Khuder, S. S., Kaw, M. K., Shou, W., Najjar, S. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311662 · Cited by 95
The Role of Aldosterone in the Metabolic Syndrome
Briet, M. B., & Schiffrin, E. L. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0182-2 · Cited by 101
“3 T3-L1 cell differentiation was blocked by MR but not by GC receptor downregulation by siRNA [28].”
BackgroundAdipose tissue renin–angiotensin–aldosterone system (RAAS) and progression of insulin resistance
Marcus, Y., Shefer, G., & Stern, N. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.021 · Cited by 97
“MR, but not glucocorticoid receptor knockdown inhibited glucocorticoid-stimulated adipose conversion of 3T3-L1 cells (Caprio et al., 2007; Guo et al., 2008).”
BackgroundRole of aldosterone and angiotensin II in insulin resistance: an update
Lastra‐Lastra, G., Sowers, J. R., Restrepo‐Erazo, K., Manrique‐Acevedo, C., & Lastra‐González, G. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03498.x · Cited by 90
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Hundemer, G. L., Leung, A. A. C., Kline, G. A., Brown, J. M., Turcu, A. F., & Vaidya, A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad024 · Cited by 97
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Roberge, C., Carpentier, A. C., Langlois, M.-F., Baillargeon, J.-P., Ardilouze, J.-L., Maheux, P., & Gallo-Payet, N. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00516.2007 · Cited by 89
“Since the inhibition of adipogenesis obtained by siRNA-induced MR downregulation is not mimicked by specific GR inactivation, MR may thus act as a proadipogenic transcription factor mediating the effects of both aldosterone and GC (37).”
Li, H., Xie, Z., Lin, J., Song, H., Wang, Q., Wang, K., Su, M., Qiu, Y., Zhao, T., Song, K., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800352k · Cited by 87
Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
Karashima, S., Yoneda, T., Kometani, M., Ohe, M., Mori, S., Sawamura, T., Furukawa, K., Seta, T., Yamagishi, M., & Takeda, Y. (2015) · Hypertension Research · doi:10.1038/hr.2015.129 · Cited by 88
Mineralocorticoid Receptors in Metabolic Syndrome: From Physiology to Disease
Feraco, A., Marzolla, V., Scuteri, A., Armani, A., & Caprio, M. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.11.006 · Cited by 85
Self-citationPatsouris, D., Neels, J. G., Fan, W., Li, P.-P., Nguyen, M. T. A., & Olefsky, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041665 · Cited by 84
Moreno‐Navarrete, J. M., & Fernández‐Real, J. M. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0965-6_2 · Cited by 115
Mineralocorticoid receptors in the metabolic syndrome
Zennaro, M., Caprio, M., & Fève, B. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.05.006 · Cited by 88
Self-citationMitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor
Lefranc, C., Friederich‐Persson, M., Palacios, R., & Cat, A. N. D. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0163 · Cited by 84
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism
Ohno, Y., Sone, M., Inagaki, N., Yamasaki, T., Ogawa, O., Takeda, Y., Kurihara, I., Umakoshi, H., Ichijo, T., Katabami, T., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00866 · Cited by 82
Transcriptional Networks Controlling Adipocyte Differentiation
Siersbaek, R., & Mandrup, S. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010512 · Cited by 74
“However, the mineralocorticoid receptor (MR) can also bind dexamethasone, and this receptor may also mediate additional effects of glucocorticoids on adipocyte differentiation (Caprio et al. 2007, 2011).”
BackgroundPrimary aldosteronism decreases insulin secretion and increases insulin clearance in humans
Adler, G. K., Murray, G. R., Turcu, A. F., Nian, H., Yu, C., Solorzano, C. C., Manning, R., Peng, D., & Luther, J. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13922 · Cited by 71
Marzolla, V., Feraco, A., Gorini, S., Mammi, C., Marrese, C., Mularoni, V., Boitani, C., Lombès, M., Kolkhof, P., Ciriolo, M. R., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000164r · Cited by 80
Self-citationMineralocorticoid Receptor Antagonists and the Metabolic Syndrome
Tirosh, A., Garg, R., & Adler, G. K. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0126-2 · Cited by 71
Hsp90 chaperones PPARγ and regulates differentiation and survival of 3T3-L1 adipocytes
Nguyễn, M. T., Csermely, P., & Sőti, C. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.129 · Cited by 77
“pathways involving Hsp90 clients (including the insulindependent PI3K pathway, the mineralocorticoid receptor, as well as calcineurin and b-catenin in Wnt signaling) may contribute to Hsp90’s effect on adipocyte differentiation and survival.(36,39,40) As an important example, we also observed a GA-induced depletion of…”
BackgroundMarzolla, V., Armani, A., Feraco, A., Martino, M. U. D., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.001 · Cited by 79
“In vitro studies showed that aldosterone as well as glucocorticoids promote murine and human white preadipocyte differentiation through MR [36,43–45].”
BackgroundSelf-citationEplerenone prevented obesity-induced inflammasome activation and glucose intolerance
Wada, T., Ishikawa, A., Watanabe, E., Nakamura, Y., Aruga, Y., Hasegawa, H., Onogi, Y., Honda, H., Nagai, Y., Takatsu, K., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0351 · Cited by 73
Faresse, N. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.015 · Cited by 84
Lattin, C. R., Waldron-Francis, K., Richardson, J. W., de Bruijn, R., Bauer, C. M., Breuner, C. W., & Romero, L. M. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.08.007 · Cited by 74
“For example, even though GR but not MR were described in human adipocytes using radioligand binding assays [37,38], MR can play a key role in adipose differentiation and function, and potentially the development of metabolic syndrome [11,56].”
BackgroundMartinerie, L., Munier, M., Menuet, D. L., Méduri, G., Viengchareun, S., & Lombès, M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.030 · Cited by 78
Self-citationChoi, S. K., Park, S., Jang, S., Cho, H. H., Lee, S., You, S., Kim, S.-H., & Moon, H. (2016) · Metabolism · doi:10.1016/j.metabol.2016.01.009 · Cited by 69
“[12] Caprio M, Feve B, Claes A.”
BackgroundMineralocorticoid receptor activation in obesity hypertension
Nagase, M., & Fujita, T. (2009) · Hypertension Research · doi:10.1038/hr.2009.86 · Cited by 72
Adipose Tissue and Adrenal Glands: Novel Pathophysiological Mechanisms and Clinical Applications
Kargi, A. Y., & Iacobellis, G. (2014) · International Journal of Endocrinology · doi:10.1155/2014/614074 · Cited by 74
“Due to the lack of adipocyte activity of 11HSD2, an enzyme which inactivates endogenous GC in mineralocorticoid target tissues, much of the observed effect of naturally occurring GC in adipocytes is due to its effect on MR, rather than GR [32] (Figure 1).”
BackgroundKuroda, K., Venkatakrishnan, R., Salker, M. S., Lucas, E. S., Shaheen, F., Kuroda, M., Blanks, A., Christian, M., Quenby, S., & Brosens, J. J. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1247 · Cited by 63
Cat, A. N. D., Antunes, T. T., Callera, G. E., Sánchez, A., Tsiropoulou, S., Dulak-Lis, M. G., Anagnostopoulou, A., He, Y., Montezano, A. C. I., Jaisser, F., et al. (2016) · Diabetes · doi:10.2337/db15-1627 · Cited by 66
“Recently, MR has been identified in adipocytes (11-14).”
BackgroundAldosterone Production and Signaling Dysregulation in Obesity
Vecchiola, A., Lagos, C. F., Carvajal, C. A., Baudrand, R. F., & Fardella, C. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0626-9 · Cited by 65
Bouligand, J., Delemer, B., Hecart, A.-C., Meduri, G., Viengchareun, S., Amazit, L., Trabado, S., Fève, B., Guiochon-Mantel, A., Young, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013563 · Cited by 60
“Glucocorticoid-activated MR could also trigger proadipogenic effects [20], or affect neuron function [21], although this needs to be investigated in patients with glucocorticoid receptor haploinsufficiency.”
BackgroundSelf-citationModulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
Muñoz‐Durango, N., Vecchiola, A., González-Gómez, L. M., Simón, F., Riedel, C. A., Fardella, C., & Kalergis, A. M. (2015) · BioMed Research International · doi:10.1155/2015/652738 · Cited by 68
“sensitive to aldosterone stimulation, such as heart [7–9], blood vessels [10], eyes [11, 12], adipose tissue [13, 14], hippocampus [15, 16], and cells of the immune system.”
BackgroundKassotis, C. D., & Stapleton, H. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00039 · Cited by 64
“Other research has evaluated the putative role of the mineralocorticoid receptor (MR), an additional high-affinity binder of glucocorticoids; treatment of 3T3-F442A and 3T3-L1 cells with the mineralocorticoid agonist aldosterone promoted adipocyte differentiation, which appeared to be mediated through PPARγ activation…”
BackgroundAssociation of plasma aldosterone with the metabolic syndrome in two German populations
Hannemann, A., Meisinger, C., Bidlingmaier, M., Döring, A., Thorand, B., Heier, M., Belcredi, P., Ladwig, K.-H., Wallaschofski, H., Friedrich, N., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1074 · Cited by 57
Feraco, A., Armani, A., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.012 · Cited by 60
Self-citationAdipocyte glucocorticoid receptor has a minor contribution in adipose tissue growth
Desarzens, S., & Faresse, N. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0121 · Cited by 55
The multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
“Glucocorticoids and aldosterone activate the MR-mediated transcription of several genes, in particular PPAR γ required for preadipocyte maturation, while selective agonists of the GR prevent maturation (66, 286).”
Interactions of the mineralocorticoid receptor – Within and without
Yang, J., & Fuller, P. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.001 · Cited by 63
Khudyakov, J. I., Champagne, C. D., Meneghetti, L. M., & Crocker, D. E. (2017) · Scientific Reports · doi:10.1038/srep42110 · Cited by 61
Lastra, G., & Sowers, J. R. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0025 · Cited by 59
“In addition, mineralocorticoid receptor (MR) is also expressed in adipose tissue [14].”
BackgroundPrimary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight
Bioletto, F., Bollati, M., Lopez, C., Arata, S., Procopio, M., Ponzetto, F., Ghigo, E., Maccario, M., & Parasiliti‐Caprino, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094803 · Cited by 62
“In fact, the MR has been identified in a wide variety of different cell types, most notably in the cardiovascular system (endothelial cells, vascular smooth muscle cells [VSMC], and cardiomyocytes) [32–36], in the neural system (hippocampal and hypothalamic neural cells) [37,38] and in the adipose tissue (adipocytes a…”
BackgroundRole of renin–angiotensin–aldosterone system in adipose tissue dysfunction
Jing, F., Mogi, M., & Horiuchi, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.03.005 · Cited by 57
Yang, J., Chang, C.-Y., Safi, R., Morgan, J., McDonnell, D. P., Fuller, P. J., Clyne, C. D., & Young, M. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0193 · Cited by 53
Matsuda, M., & Shimomura, I. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0001 · Cited by 58
“Glucocorticoids are a potent regulator of adipose differentiation, which is mediated by MR [107].”
BackgroundPharmacological and non-pharmacological interventions to influence adipose tissue function
Westerink, J., & Visseren, F. L. J. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-13 · Cited by 60
“tone [98].”
Lipocalin-2 - the myth of its expression and function.
Li, D., Sun, W. Y., Fu, B., Xu, A., & Wang, Y. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13332 · Cited by 47
Impact of Adrenal Steroids on Regulation of Adipose Tissue
Infante, M., Armani, A., Mammi, C., Fabbri, A., & Caprio, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160037 · Cited by 60
Self-citationThe mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?
Farman, N., Maubec, E., Pöeggeler, B., Klatte, J. E., Jaisser, F., & Paus, R. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01011.x · Cited by 56
Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess
Pivonello, R., Martino, M. C. D., Iacuaniello, D., Simeoli, C., Muscogiuri, G., Carlomagno, F., Leo, M. D., Cozzolino, A., & Colao, A. (2016) · Frontiers of hormone research · doi:10.1159/000443864 · Cited by 56
Berra, C., Manfrini, R., Regazzoli, D., Radaelli, M. G., Disoteo, O., Sommese, C., Fiorina, P., Ambrosio, G., & Folli, F. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105052 · Cited by 48
Boscaro, M., Giacchetti, G., & Ronconi, V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06597.x · Cited by 55
Links between aldosterone excess and metabolic complications: A comprehensive review
Bothou, C., Beuschlein, F., & Spyroglou, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.003 · Cited by 57
Androgen receptor expression during C2C12 skeletal muscle cell line differentiation
Wannenes, F., Caprio, M., Gatta, L., Fabbri, A., Bonini, S., & Moretti, C. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.05.018 · Cited by 50
Self-citation
Metadata
- Authors
- Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C.
- Affiliations
- University of Rome Tor Vergata (IT)
- Université Paris-Sud (FR)
- Inserm (FR)
- Corresponding author
- Zennaro, Maria-Christina
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-03-23
- Volume
- 21
- Issue
- 9
- Pages
- 2185-2194
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2020602591
- Semantic Scholar
- 734801b485ad9565f37131d53cbad945c833d55c
- Cited by
- 337
- References
- 37
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 7 · 2023: 13 · 2022: 15 · 2021: 8 · 2020: 18 · 2019: 13 · 2018: 19 · 2017: 20 · 2016: 26 · 2015: 30 · 2014: 36 · 2013: 23 · 2012: 18
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Funders
- Fondation pour la Recherche Médicale
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- mineralocorticoid receptor, aldosterone, adipogenesis, 3T3-L1 cells, dexamethasone, PPARγ, spironolactone, glucocorticoid receptor, obesity, metabolic syndrome, transcriptional regulation
- MeSH terms
- Aldosterone, Animals, Cell Differentiation, Cells, Cultured, Dexamethasone, Dose-Response Relationship, Drug, Insulin, Male, Obesity, Phenotype, Receptors, Glucocorticoid, RNA, Messenger, Spironolactone, Transcription, Genetic, Receptors, Mineralocorticoid, Metabolic Syndrome, RNA, Small Interfering, Swiss 3T3 Cells, PPAR gamma, Adipogenesis, Mice, Adipose Tissue, White, Adipocytes, White
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.